What is Five Star Diagnostics?
Five Star Diagnostics operates as a mobile diagnostic service provider dedicated to enhancing patient outcomes for individuals with diabetes. The company specializes in diabetic retinopathy exams, leveraging telemedicine to facilitate the secure transmission of retinal images and diagnostic reports to healthcare providers. Its service model is designed to serve a broad clientele, including health plans, health systems, physicians, and patients, with a core commitment to delivering exceptional customer service and fostering enduring partnerships. By improving access to essential eye exams, Five Star Diagnostics actively works to mitigate the incidence of preventable blindness.
How much funding has Five Star Diagnostics raised?
Five Star Diagnostics has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
What's next for Five Star Diagnostics?
With the recent influx of expansion capital, Five Star Diagnostics is poised for significant operational scaling and service enhancement. The company's strategic focus on telemedicine-powered diabetic retinopathy screening positions it to capture a larger share of the healthcare market, particularly within underserved or remote patient populations. Future developments are likely to involve expanding service reach, further integrating innovative medical devices, and strengthening partnerships with healthcare entities to solidify its role in preventative care and chronic disease management. This investment will be critical in advancing their mission to close the gap in preventable blindness.
See full Five Star Diagnostics company page
